Benzinga | Aug 6, 2020 08:09AM EDT

Insmed Q2 EPS $(0.64) Misses $(0.63) Estimate, Sales $42.50M Beat $34.51M Estimate

Insmed (NASDAQ:INSM) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.63) by 1.59 percent. This is a 20.99 percent increase over losses of $(0.81) per share from the same period last year. The company reported quarterly sales of $42.50 million which beat the analyst consensus estimate of $34.51 million by 23.15 percent. This is a 41.80 percent increase over sales of $29.97 million the same period last year.